Whole blood RNA signatures in tuberculosis patients receiving H56:IC31 vaccine as adjunctive therapy

DiscussionOur data report gene expression patterns following H56:IC31 vaccination which might be interpreted as a lower risk of relapse in therapeutically vaccinated patients. Further studies are needed to conclude if these gene expression patterns could be used as prognostic biosignatures for therapeutic TB vaccine responses.
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research